ENDRA LIFE SCIENCES INC. (NDRA) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -6.65M USD | Operating Income (Loss) |
| Revenue | (m) | |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 1.95M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-6.65M | (m) | (m) | $1.95M | (m) | (m) |
| 2026-03-31 | $-6.47M | (m) | (m) | $2.10M | (m) | (m) |
| 2025-12-31 | $-5.76M | (m) | (m) | $1.85M | (m) | (m) |
| 2025-09-30 | $-8.44M | (m) | (m) | $1.98M | (m) | (m) |
| 2025-06-30 | $-8.58M | (m) | (m) | $2.34M | (m) | (m) |
| 2025-03-31 | $-9.51M | (m) | (m) | $2.68M | (m) | (m) |
| 2024-12-31 | $-10.82M | (m) | (m) | $3.19M | (m) | (m) |
| 2024-09-30 | $-7.98M | (m) | (m) | $3.13M | (m) | (m) |
| 2024-06-30 | $-9.60M | (m) | (m) | $3.97M | (m) | (m) |
| 2024-03-31 | $-10.36M | (m) | (m) | $4.65M | (m) | (m) |
| 2023-12-31 | $-10.52M | (m) | (m) | $5.00M | (m) | (m) |
| 2023-09-30 | $-12.38M | (m) | (m) | $6.09M | (m) | (m) |
| 2023-06-30 | $-12.66M | (m) | (m) | $6.29M | (m) | (m) |
| 2023-03-31 | $-13.24M | (m) | (m) | $6.73M | (m) | (m) |
| 2022-12-31 | $-13.16M | (m) | (m) | $6.55M | (m) | (m) |
| 2022-09-30 | $-12.92M | (m) | (m) | $6.31M | (m) | (m) |
| 2022-06-30 | $-12.15M | (m) | (m) | $5.66M | (m) | (m) |
| 2022-03-31 | $-11.78M | (m) | (m) | $5.55M | (m) | (m) |
| 2021-12-31 | $-11.50M | (m) | (m) | $5.48M | (m) | (m) |
| 2021-09-30 | $-10.68M | (m) | (m) | $5.20M | (m) | (m) |
| 2021-06-30 | $-11.29M | (m) | (m) | $5.80M | (m) | (m) |
| 2021-03-31 | $-10.98M | (m) | (m) | $5.54M | (m) | (m) |
| 2020-12-31 | $-11.50M | $0.00 | (m) | $5.92M | (m) | (m) |
| 2020-09-30 | $-12.38M | (m) | (m) | $6.80M | (m) | (m) |
| 2020-06-30 | $-11.76M | (m) | (m) | $6.50M | (m) | (m) |
| 2020-03-31 | $-11.20M | (m) | (m) | $6.32M | (m) | (m) |
| 2019-12-31 | $-10.84M | $0.00 | (m) | $6.57M | (m) | (m) |
| 2019-09-30 | $-9.72M | $0.00 | (m) | $5.60M | (m) | (m) |
| 2019-06-30 | $-9.43M | $0.00 | (m) | $5.29M | (m) | (m) |
| 2019-03-31 | $-8.93M | $0.00 | (m) | $4.83M | (m) | (m) |
| 2018-12-31 | $-9.02M | $6.17K | (m) | $4.72M | (m) | -146080.47% |
| 2018-09-30 | $-9.31M | $13.02K | (m) | $5.03M | (m) | -71504.70% |
| 2018-06-30 | $-7.87M | $300.02K | (m) | $4.17M | (m) | -2622.85% |
| 2018-03-31 | $-7.10M | $357.80K | (m) | $3.50M | (m) | -1985.20% |
| 2017-12-31 | $-4.63M | $351.62K | (m) | $1.93M | (m) | -1315.63% |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $-1.79M | $515.58K | (m) | $495.38K | (m) | -347.52% |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |